The guideline was designed to help researchers and regulators conduct surveillance or studies of medicine quality (falsified and substandard medicines), using mystery shopper techniques. This practical toolkit based on STARmeds samples, around 1200 drug samples consisting of 5 molecules collected from 8 districts/cities in Indonesia. Writers: Jenny Pontoan, Mawaddati Rahmi, Ayu Rahmawati, Hesty Utami, Esti Mulatsari, William Nathanial and Elizabeth Pisani.
Substandard and Falsified Medicines: Proposed Methods for Case Finding and Sentinel Surveillance
Pisani E, Hasnida A, Rahmi M, Kok M, Harsono S, Anggriani Y
JMIR Public Health Surveill 2021;7(8):e29309. DOI: 10.2196/29309
Challenges in Maintaining Medicine Quality While Aiming for Universal Health Coverage: A Qualitative Analysis from Indonesia
Hasnida, Amalia, Maarten Olivier Kok and Elizabeth Pisani.
BMJ Global Health 6(Suppl. 3): e003663. doi.org/10.1136/bmjgh-2020-003663
Is Indonesia Achieving Universal Health Coverage? Secondary Analysis of Nationa Data on Insurance Coverage, Health Spending, and Service Availability
Pratiwi, Agnes Bhakti, Hermawati Setiyaningsih, Maarten Olivier Kok, Trynke Hoekstra, Ali Ghufron Mukti and Elizabeth Pisani.
BMJ Open 11(10): e050565. doi.org/10.1136/bmjopen-2021-050565
The impact of pharmaceutical policies on medicine procurement pricing in Indonesia under the implementation of Indonesia’s social health insurance system
Anggriani, Yusi, Hesty Utami Ramadaniati, Prih Sarnianto, Jenny Pontoan and Sri Suryawati.
Value in Health Regional Issues 21: 1–8. doi.org/10.1016/j.vhri.2019.05.005
Identifying market risk for substandard and falsified medicines: An analytic framework based on qualitative research in China, Indonesia, Turkey and Romania
Pisani, Elizabeth, Adina-Loredana Nistor, Amalia Hasnida, Koray Parmaksiz, Jingying Xu and Maarten Oliver Kok.
Wellcome Open Research 4: 70. doi.org/10.12688/wellcomeopenres.15236.1
Indonesia’s road to universal health coverage: A Political Journey
Pisani, Elizabeth, Maarten Oliver Kok and Kharisma Nugroho.
Health Policy and Planning 32(2): 267–76. doi.org/10.1093/heapol/czw120
The impact of Indonesian Generic Medicine Pricing Policy on Medicine Prices
Anggriani, Yusi, Mohamed Izham M. Ibrahim, Sri Suryawati and Asrul A. Shafie.
Journal of Generic Medicines 10(3–4): 219–29. doi.org/10.1177/1741134314553605
*: Some of these studies were conducted prior to STARmeds, by some of the researchers who are also involved in STARmeds. All these studies compliment one another, to improve our understanding of medicine quality, mainly in Indonesia